InsidersTradesSigma
Follow the 셀바스헬스케어 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 셀바스헬스케어 has recorded 1 public disclosures. Market capitalisation: €64.2bn. The latest transaction was disclosed on 9 April 2026 (Purchase). Among the most active insiders: 한국증권금융. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Selvas Healthcare is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative health solutions and medical technologies.